Hendley & CO Inc Zoetis Inc. Transaction History

Hendley & CO Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$165.67 - $199.94 $48,209 - $58,182	291 Added 1.12%	26,275 $4.45 Million
Q4 2023 Jan 26, 2024	SELL	$151.44 - $200.09 $69,359 - $91,641	-458 Reduced 1.73%	25,984 $5.13 Million
Q3 2023 Oct 25, 2023	BUY	$167.14 - $192.77 $61,006 - $70,361	365 Added 1.4%	26,442 $4.6 Million
Q2 2023 Aug 11, 2023	BUY	$160.94 - $186.23 $24,945 - $28,865	155 Added 0.6%	26,077 $4.49 Million
Q1 2023 Apr 24, 2023	SELL	$145.48 - $175.02 $269,719 - $324,487	-1,854 Reduced 6.67%	25,922 $4.31 Million
Q4 2022 Jan 24, 2023	BUY	$131.14 - $157.47 $23,080 - $27,714	176 Added 0.64%	27,776 $4.07 Million
Q3 2022 Oct 20, 2022	BUY	$148.29 - $182.55 $4.09 Million - $5.04 Million	27,600 New	27,600 $4.09 Million

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Hendley & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Hendley & CO Inc with notifications on news.